首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >PDA stenting in 6-month-old infant with suprasystemic pulmonary hypertension as a treatment option for hypertensive crisis
【24h】

PDA stenting in 6-month-old infant with suprasystemic pulmonary hypertension as a treatment option for hypertensive crisis

机译:PDA支架置入6个月大的上系统性肺动脉高压婴儿作为高血压危象的治疗选择

获取原文
       

摘要

Introduction Pulmonary arterial hypertension is a severe disease with limited therapeutic options. When pharmacological treatment for children under 1 year is insufficient, surgical palliative options include the Potts shunt, creating an interatrial connection and interventional PDA stenting. Aim We present a case of a 6-month-old patient with suprasystemic pulmonary hypertension in whom we implanted a stent into the residual persistent arterial duct allowing decompression of the right ventricle and clinical stabilization. Case report A 6-month-old patient weighing 5.5 kg was admitted to the Pediatric Cardiology Department for cardiac catheterization due to pulmonary hypertension (PH). PH was diagnosed at 2 months and oral medication was started. Regular outpatient monitoring showed failure to thrive, progression of echocardiographic changes with growing disproportion between ventricles due to right ventricle dilatation, and rising NTproBNP levels (4214 pg/ml to 8111 pg/ml before intervention). Echocardiographic examination upon admission showed an enlarged right ventricle with hyperkinetic interventricular septum, residual 0.5–1 mm patent ductus arteriosus (PDA) shunting right-left with pressure gradient 55 mm Hg, small foramen ovale with no visible shunting across the interatrial septum, dilated right ventricle, borderline diameter of the mitral valve, aortic valve and compressed left ventricle (Figure 1). During hospitalization due to rapid deterioration of the patient’s condition, poor response to oral medication (maximum dose of sildenafil), and progressing signs of low cardiac output we decided on urgent cardiac catheterization with implantation of a stent into the patent ductus arteriosus to minimize the risk of pulmonary hypertensive crisis. We prepared an appropriate anesthetic management plan and were ready to treat pulmonary hypertensive crisis if it occurred during intervention. After initiation of general anesthesia cardiac catheterization was performed through the femoral vein and artery, and pressure measurements were taken in the right atrium, right ventricle and pulmonary artery. Pulmonary wedge pressure was assessed. The catheter was then threaded through the small patent foramen ovale (PFO) allowing the measurement of pressures in the left atrium and ventricle. Taking into account all measurements pulmonary hypertension was confirmed (Figure 2). After passing coronary guidewire 0.014...
机译:引言肺动脉高压是一种严重的疾病,治疗选择有限。当对1岁以下儿童的药理治疗不足时,外科姑息治疗方法包括Potts分流术,建立心房连接和介入性PDA支架。目的我们介绍了一个6个月大的上系统性肺动脉高压患者,在该患者中,我们将一个支架植入残余的持续性动脉导管中,以使右心室减压并实现临床稳定。病例报告一名6个月大,重5.5公斤的患者因肺动脉高压(PH)被送入儿科心脏病科进行心脏导管插入术。在2个月时诊断出PH并开始口服药物。定期的门诊监测显示,患者心律不齐,超声心动图改变的进展(由于右心室扩张导致心室间比例越来越大)和NTproBNP水平升高(干预前从4214 pg / ml增至8111 pg / ml)。入院时的超声心动图检查显示右室增大,室间隔亢进,右动脉左0.5–1 mm动脉导管未闭(PDA)分流,压力梯度55 mm Hg,卵圆形小孔,房间隔无可见分流,右扩张心室,二尖瓣,主动脉瓣和压缩的左心室的边界线直径(图1)。在住院期间,由于患者的病情迅速恶化,对口服药物的反应较差(西地那非的最大剂量)以及出现低心输出量的迹象,我们决定紧急进行心脏导管插入术,将支架植入动脉导管未闭以最大程度地降低风险肺动脉高压危机。我们准备了适当的麻醉管理计划,并准备好在干预过程中治疗发生的肺动脉高压危机。全身麻醉开始后,通过股静脉和动脉进行心脏导管插入术,并在右心房,右心室和肺动脉进行压力测量。评估肺楔压。然后将导管穿过小卵圆孔(PFO),以测量左心房和心室中的压力。考虑到所有测量结果,证实了肺动脉高压(图2)。通过冠状动脉导丝后0.014 ...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号